These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery. Sayin B; Somavarapu S; Li XW; Thanou M; Sesardic D; Alpar HO; Senel S Int J Pharm; 2008 Nov; 363(1-2):139-48. PubMed ID: 18662762 [TBL] [Abstract][Full Text] [Related]
3. Enhanced immune response with a combination of alum and biodegradable nanoparticles containing tetanus toxoid. Raghuvanshi RJ; Mistra A; Talwar GP; Levy RJ; Labhasetwar V J Microencapsul; 2001; 18(6):723-32. PubMed ID: 11695637 [TBL] [Abstract][Full Text] [Related]
4. Nanoparticle-based immunopotentiation via tetanus toxoid-loaded gelatin and aminated gelatin nanoparticles. Sudheesh MS; Vyas SP; Kohli DV Drug Deliv; 2011 Jul; 18(5):320-30. PubMed ID: 21351824 [TBL] [Abstract][Full Text] [Related]
5. Improved immune response from biodegradable polymer particles entrapping tetanus toxoid by use of different immunization protocol and adjuvants. Raghuvanshi RS; Katare YK; Lalwani K; Ali MM; Singh O; Panda AK Int J Pharm; 2002 Oct; 245(1-2):109-21. PubMed ID: 12270248 [TBL] [Abstract][Full Text] [Related]
6. In vivo efficacy and toxicity evaluation of polycaprolactone nanoparticles and aluminum based admixture formulation as vaccine delivery system. Bansal V; Kumar M; Bhardwaj A; Brahmne HG; Singh H Vaccine; 2015 Oct; 33(42):5623-5632. PubMed ID: 26343498 [TBL] [Abstract][Full Text] [Related]
7. Enhanced mucosal immune responses against tetanus toxoid using novel delivery system comprised of chitosan-functionalized gold nanoparticles and botanical adjuvant: characterization, immunogenicity, and stability assessment. Barhate G; Gautam M; Gairola S; Jadhav S; Pokharkar V J Pharm Sci; 2014 Nov; 103(11):3448-3456. PubMed ID: 25219511 [TBL] [Abstract][Full Text] [Related]
8. Immunological evaluation of chitosan nanoparticles loaded with tetanus toxoid. Ghalavand M; Saadati M; Ahmadi A; Abbasi E; Salimian J Bratisl Lek Listy; 2018; 119(2):71-74. PubMed ID: 29455539 [TBL] [Abstract][Full Text] [Related]
9. Influences of excipients on in vitro release and in vivo performance of tetanus toxoid loaded polymer particles. Katare YK; Panda AK Eur J Pharm Sci; 2006 Jun; 28(3):179-88. PubMed ID: 16517132 [TBL] [Abstract][Full Text] [Related]
10. Potentiation of immune response from polymer-entrapped antigen: toward development of single dose tetanus toxoid vaccine. Katare YK; Panda AK; Lalwani K; Haque IU; Ali MM Drug Deliv; 2003; 10(4):231-8. PubMed ID: 14612338 [TBL] [Abstract][Full Text] [Related]
12. Augmentation of humoral and cellular immunity in response to Tetanus and Diphtheria toxoids by supercritical carbon dioxide extracts of Hippophae rhamnoides L. leaves. Jayashankar B; Singh D; Tanwar H; Mishra KP; Murthy S; Chanda S; Mishra J; Tulswani R; Misra K; Singh SB; Ganju L Int Immunopharmacol; 2017 Mar; 44():123-136. PubMed ID: 28092864 [TBL] [Abstract][Full Text] [Related]
13. Immunoadjuvant potential of cross-linked dextran microspheres mixed with chitosan nanospheres encapsulated with tetanus toxoid. Pirouzmand H; Khameneh B; Tafaghodi M Pharm Biol; 2017 Dec; 55(1):212-217. PubMed ID: 27927058 [TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and protection in small-animal models with controlled-release tetanus toxoid microparticles as a single-dose vaccine. Singh M; Li XM; Wang H; McGee JP; Zamb T; Koff W; Wang CY; O'Hagan DT Infect Immun; 1997 May; 65(5):1716-21. PubMed ID: 9125552 [TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and lower dose requirement of polymer entrapped tetanus toxoid co-administered with alum. Katare YK; Panda AK Vaccine; 2006 Apr; 24(17):3599-608. PubMed ID: 16513224 [TBL] [Abstract][Full Text] [Related]
16. Quillaja saponaria extract as mucosal adjuvant with chitosan functionalized gold nanoparticles for mucosal vaccine delivery: stability and immunoefficiency studies. Barhate G; Gautam M; Gairola S; Jadhav S; Pokharkar V Int J Pharm; 2013 Jan; 441(1-2):636-42. PubMed ID: 23117021 [TBL] [Abstract][Full Text] [Related]
17. Influence of particle size, antigen load, dose and additional adjuvant on the immune response from antigen loaded PLA microparticles. Katare YK; Muthukumaran T; Panda AK Int J Pharm; 2005 Sep; 301(1-2):149-60. PubMed ID: 16023313 [TBL] [Abstract][Full Text] [Related]
18. Fabrication of nanoadjuvant with poly-ε-caprolactone (PCL) for developing a single-shot vaccine providing prolonged immunity. Prashant CK; Bhat M; Srivastava SK; Saxena A; Kumar M; Singh A; Samim M; Ahmad FJ; Dinda AK Int J Nanomedicine; 2014; 9():937-50. PubMed ID: 24611010 [TBL] [Abstract][Full Text] [Related]
19. Adjuvants for Clostridium tetani and Clostridium diphtheriae vaccines updating. Alshanqiti FM; Al-Masaudi SB; Al-Hejin AM; Redwan EM Hum Antibodies; 2017; 25(1-2):23-29. PubMed ID: 27858706 [TBL] [Abstract][Full Text] [Related]
20. The influence of molecular adjuvants in the cutaneous response to antigen after topical vaccination. Himes R; Lee S; McMenigall K; Russell-Jones G Vaccine; 2011 Jul; 29(33):5393-8. PubMed ID: 21664219 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]